Free Trial

Afya (AFYA) Stock Price, News & Analysis

-0.34 (-2.07%)
(As of 06/12/2024 ET)
Today's Range
50-Day Range
52-Week Range
126,789 shs
Average Volume
124,596 shs
Market Capitalization
$1.51 billion
P/E Ratio
Dividend Yield
Price Target

Afya MarketRank™ Stock Analysis

Analyst Rating
2.00 Rating Score
42.9% Upside
$23.00 Price Target
Short Interest
7.26% of Float Sold Short
Dividend Strength
News Sentiment
0.83mentions of Afya in the last 14 days
Based on 5 Articles This Week
Insider Trading
Proj. Earnings Growth
From $1.50 to $1.82 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.40 out of 5 stars

Consumer Discretionary Sector

126th out of 267 stocks

Educational Services Industry

9th out of 21 stocks

AFYA stock logo

About Afya Stock (NASDAQ:AFYA)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

AFYA Stock Price History

AFYA Stock News Headlines

Analyzing Afya (NASDAQ:AFYA) and QuantaSing Group (NASDAQ:QSG)
Afya (NASDAQ:AFYA) Stock Price Up 2%
AFYA: Mr Market Is Mistaken
See More Headlines
Receive AFYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Afya and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Educational services
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
3 Analysts


Net Income
$77.38 million
Pretax Margin


Sales & Book Value

Annual Sales
$576.09 million
Cash Flow
$1.80 per share
Book Value
$7.79 per share


Free Float
Market Cap
$1.51 billion
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

AFYA Stock Analysis - Frequently Asked Questions

Should I buy or sell Afya stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Afya in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" AFYA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFYA, but not buy additional shares or sell existing shares.
View AFYA analyst ratings
or view top-rated stocks.

What is Afya's stock price target for 2024?

3 Wall Street research analysts have issued 1-year price targets for Afya's stock. Their AFYA share price targets range from $23.00 to $23.00. On average, they predict the company's share price to reach $23.00 in the next twelve months. This suggests a possible upside of 42.9% from the stock's current price.
View analysts price targets for AFYA
or view top-rated stocks among Wall Street analysts.

How have AFYA shares performed in 2024?

Afya's stock was trading at $21.93 at the beginning of 2024. Since then, AFYA stock has decreased by 26.6% and is now trading at $16.10.
View the best growth stocks for 2024 here

When is Afya's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 26th 2024.
View our AFYA earnings forecast

How were Afya's earnings last quarter?

Afya Limited (NASDAQ:AFYA) posted its earnings results on Thursday, May, 9th. The company reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.07. The company had revenue of $162.45 million for the quarter, compared to analysts' expectations of $152.98 million. Afya had a trailing twelve-month return on equity of 17.51% and a net margin of 16.20%.

What ETFs hold Afya's stock?

ETFs with the largest weight of Afya (NASDAQ:AFYA) stock in their portfolio include BNY Mellon Sustainable Global Emerging Markets ETF (BKES).VanEck Brazil Small-Cap ETF (BRF).

What guidance has Afya issued on next quarter's earnings?

Afya updated its FY 2024 earnings guidance on Friday, May, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $636.4 million-$656.6 million, compared to the consensus revenue estimate of $626.5 million.

What other stocks do shareholders of Afya own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Afya investors own include Pfizer (PFE), Cisco Systems (CSCO), Procter & Gamble (PG), RTX (RTX), Abbott Laboratories (ABT), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA) and CSX (CSX).

When did Afya IPO?

Afya (AFYA) raised $233 million in an initial public offering on Friday, July 19th 2019. The company issued 13,700,000 shares at $16.00-$18.00 per share. BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itaú BBA, Morgan Stanley, BTG and Pactual XP Investments acted as the underwriters for the IPO.

Who are Afya's major shareholders?

Afya's stock is owned by many different institutional and retail investors. Top institutional investors include Bamco Inc. NY (3.17%), Perpetual Ltd (0.72%), DekaBank Deutsche Girozentrale (0.03%), Lifestyle Asset Management Inc. (0.01%), Daiwa Securities Group Inc. (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Afya?

Shares of AFYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AFYA) was last updated on 6/13/2024 by Staff

From Our Partners